Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dimension Therapeutics, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dimension Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Dimension Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is DMTX. The reporting company's CIK number is 1592288.
The total value of stock buying since 2005 is $17,699,994.
The total value of stock sales since 2005 is $50,000.
The total value of stock option exercises since 2005 is $1,900.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2016-06-07||Clark K. Reed (SVP of Pharmaceutical Develop)||Sale||5,000||10.00||50,000|
|2016-06-07||Clark K. Reed (SVP of Pharmaceutical Develop)||Option Ex||5,000||.38||1,900|
|2015-10-27||Dybbs Michael (Director)||Buy||961,538||13.00||12,499,994|
|2015-10-27||Gupta Rishi (Director)||Buy||200,000||13.00||2,600,000|
|2015-10-27||Isaly Samuel D (Director)||Buy||200,000||13.00||2,600,000|
Insider trading activities including stock purchases, stock sales, and option exercises of DMTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dimension Therapeutics, Inc. (symbol DMTX, CIK number 1592288) see the Securities and Exchange Commission (SEC) website.